This compound is a polyacetylated pharmaceutical intermediate featuring a complex bicyclic core with multiple ether and ester functional groups. It is structurally identified as a synthetic building block for the manufacture of specialized active pharmaceutical ingredients.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1298086-18-6
2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoic acid
Pharmaceutical intermediate for adenosine monophosphate impurities
(S)-Glycidyl Trityl Ether
Pharmaceutical intermediate
PAMOIC ACID
Pharmaceutical intermediate and reference standard
1-(4-Chlorobenzhydryl)piperazine
pharmaceutical intermediate
Ertugliflozin
active pharmaceutical ingredient
Ertugliflozin pidolate
active pharmaceutical ingredient for diabetes
[(1R,2S,3S,4R,5S)-2,3,4-triacetyloxy-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6,8-dioxabicyclo[3.2.1]octan-1-yl]methyl acetate
LFZVLROKLDGLRV-KTBGKDHWSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)Cl